Ads
related to: dangers of hep c treatment drugs names and prices today video- A Hep C Treatment Regimen
Ready To Treat Your Hep C?
Learn About A Treatment Option Here
- Find A Hep C Provider
Ready To Take The Next Step? Find
A Hep C Provider Near You Today!
- Risks Of Hepatitis C
Read About The Risks Of Hep C And
Explore A Hep C Treatment Here.
- Patient Support Program
Looking For Financial Assistance &
Insurance Support? Learn More Here.
- Download A Co-Pay Coupon
Eligible Patients May Pay As Little
As $5 Per Co-Pay For A Treatment
- Talk To Your Provider
Download A Conversation Guide And
Learn About A Treatment Option Here
- A Hep C Treatment Regimen
Search results
Results From The WOW.Com Content Network
Sofosbuvir, sold under the brand name Sovaldi among others, is a medication used to treat hepatitis C. [3] It is taken by mouth. [3] [6]Common side effects include fatigue, headache, nausea, and trouble sleeping. [3]
In all cases, after just 12 weeks of treatment, 95 percent of people diagnosed with hepatitis C are cured. How to Prevent Hepatitis C Cured of hepatitis C, however, doesn’t mean immune.
Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [2] [5] [6] [7] It combines sofosbuvir and velpatasvir. [2] [5] [6] It is more than 90% effective for hepatitis C genotypes one through six. [2]
Hepatitis C is spread primarily by blood-to-blood contact, associated with intravenous drug use, poorly sterilized medical equipment, needlestick injuries in healthcare, and transfusions. [2] [4] It may also be spread from an infected mother, to her baby during birth. [2]
There is no vaccine against hepatitis C. [1] [9] Prevention includes harm reduction efforts among people who inject drugs, testing donated blood, and treatment of people with chronic infection. [ 4 ] [ 10 ] Chronic infection can be cured more than 95% of the time with antiviral medications such as sofosbuvir or simeprevir .
The FDA placed a partial clinical hold on a key next-generation hepatitis-C drug at the end of last week, and this week's second-quarter earnings were a mixed bag, sending shares FDA Slams Brakes ...
Ads
related to: dangers of hep c treatment drugs names and prices today video